Evolent Health
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.99 | -100% | -52.22 | -100% |
| P/S |
|
1.82 | 4.07 | -55.36% |
|
|
| P/BV |
|
3.34 | 9.41 | -64.49% |
|
|
| P/FCF |
|
26.27 | 46.88 | -43.98% |
|
|
| Ev/Ebitda |
|
86.69 | 17.44 | 397.04% |
|
|
| Ev/S |
|
2.05 | 4.38 | -53.26% |
|
|
| Ev/FCF |
|
35.32 | 55.55 | -36.42% |
|
|
| E/P |
|
-0.0378 | 0.2163 | -117.47% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
2.36 | 20.21 | -88.31% | 1.49 | 59.01% |
| ROE |
|
-10.59 | -80.94 | -86.92% |
|
|
| ROA |
|
-4.22 | 6.66 | -163.29% |
|
|
| ROIC |
|
-2.2 | 15.68 | -114.03% |
|
|
| ROS |
|
-5.76 | 10.5 | -154.85% |
|
|
| ROCE |
|
-7.21 | 19.22 | -137.53% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
13.08 | 2.86 | 356.89% | 22.01 | -40.55% |
| Nеt Debt/Ebitda |
|
9.74 | 3.72 | 162.31% |
|
|
| Debt/Ratio |
|
0.2264 | 0.2638 | -14.17% |
|
|
| Debt/Equity |
|
6.9 | 4.81 | 43.47% |
|
|
| Debt/Net Income |
|
-5.37 | 6.51 | -182.47% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.24 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.9365 | -100% |
|
|
| DSI |
|
0 | 0.7161 | -100% |
|
|
| Average dividend growth |
|
0 | -0.182 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.26 | -100% |
|
|
| Average percentage for payments |
|
16.63 | 77.6 | -78.58% |
|
|
| Difference from average difference in sector |
|
-1.24 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
132.03 | 446.18 | -70.41% |
| Growth impulse Ebitda 5 years |
|
-170.81 | 615.43 | -127.75% |
| Growth impulse Net Income 5 years |
|
-63.01 | 553.09 | -111.39% |
| Growth impulse FCF 5 years |
|
-245.57 | 330.41 | -174.32% |
| Growth impulse EPS 5 years |
|
-72.61 | 549.99 | -113.2% |
IP Score
2.14/10
